Position in ABBV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$287,141,170
+$19,898,125 QoQ
Shares Held
1,320,250
+12.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $2,170,128,870 across 11 Drug Manufacturers - General names. ABBV ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
760,386 | $699,380,229 | |
| 2 | JNJ |
Johnson & Johnson
|
2,072,836 | $506,684,030 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,320,250 | $287,141,170 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,779,179 | $214,017,440 | |
| 5 | AMGN |
Amgen Inc
|
433,304 | $152,458,010 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
857,393 | $119,494,861 | |
| 7 | PFE |
Pfizer Inc
|
3,368,279 | $94,581,273 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,445,624 | $87,677,094 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $287,141,170 | 1,320,250 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $267,243,045 | 1,169,605 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $279,608,861 | 1,207,605 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $244,769,853 | 1,318,661 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $273,859,191 | 1,307,079 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $192,939,906 | 1,085,762 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $229,240,707 | 1,160,830 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $187,224,198 | 1,091,559 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $215,788,499 | 1,185,000 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||